A pharmacy that fills a prescription and gets reimbursed less than what it paid the wholesaler for the drug is being paid under a Pharmacy Benefit Manager's (PBM) Maximum Allowable Cost (MAC) list, the pricing benchmark a PBM uses to set what it will pay for a multi-source generic drug regardless of what the pharmacy actually paid to acquire it. When the MAC price sits below acquisition cost, the pharmacy loses money on every fill until the list is corrected or the claim is successfully appealed. Most states now require PBMs to operate a formal MAC appeal process, but the filing window is short, often measured in business days, and a pharmacy that misses it, or files an incomplete recoupment record instead of a pricing record, forfeits the correction.
How MAC Pricing Sets Pharmacy Reimbursement
A MAC list assigns a single reimbursement ceiling to a generic drug, built from wholesaler pricing data, national pricing compendia, and the PBM's own claims history. The pharmacy is paid the MAC price on the claim regardless of the price it actually paid its wholesaler that week. Generic drug pricing moves quickly, and a MAC list that lags the market, or that is built on national pricing an independent pharmacy cannot actually obtain, can set reimbursement below what any pharmacy in the state can buy the drug for. That gap is a pricing dispute, distinct from an audit finding or a documentation-based recoupment demand, and it is corrected through the MAC appeal process rather than an audit appeal.
State MAC Appeal Mandates Vary by Jurisdiction
The MAC appeal right comes from state legislatures, not from the PBMs. The National Academy for State Health Policy tracks PBM legislation nationally and reports that all 50 states now regulate PBMs in some form, and a MAC transparency or appeal mandate is a common feature of that regulation. The general shape is consistent across states: the PBM must maintain a defined appeal channel, respond within a set number of days, and either adjust the price and permit the pharmacy to reverse and rebill the claim, or deny the appeal and disclose the National Drug Code and wholesaler source supporting the reimbursement. The details vary sharply by state. Oklahoma requires an administrative appeal within 10 business days of the final adjusted payment date and a PBM response within 10 business days, under 59 O.S. § 360. Mississippi gives pharmacies 30 business days to file and requires the PBM to resolve the appeal, by price adjustment or a documented denial, within 30 business days, under Miss. Code § 73-21-156. A pharmacy operating across state lines cannot rely on one state's deadline for a claim filed under another state's contract.
Building the Record of Below-Acquisition-Cost Reimbursement
A MAC appeal succeeds or fails on the record the pharmacy submits, not on the fact that the reimbursement felt low. The PBM's appeal form typically asks for the wholesaler or manufacturer the pharmacy purchased from, and the pharmacy should also attach the underlying invoice: the National Drug Code, quantity, unit price, and invoice date, matched to the date of the claim at issue. This is the same invoice reconciliation discipline pharmacies use to answer an inventory shortage finding in a PBM audit, applied instead to a pricing claim. A single invoice showing one favorable price is weaker than a documented pattern across several fills and, where available, more than one wholesaler source. Pharmacies should also track the date the claim was submitted against the state's filing window; an appeal that is accurate on the merits but filed a day late can be rejected on timing alone.
The MAC appeal window can close before a pharmacy finishes gathering the wholesaler invoices needed to win it.
Why Early Legal Counsel Is Critical
It is critical that pharmacies promptly retain experienced healthcare defense counsel when reimbursement falls below acquisition cost or a MAC appeal is denied. Early legal intervention can protect the pharmacy's rights, ensure the appeal record is built correctly and timely within the state's filing window, avoid procedural forfeiture, and allow counsel to communicate with the PBM on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the pharmacy to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance represents pharmacies nationwide in MAC pricing disputes as part of the firm's PBM audit defense practice, building the wholesaler and NDC-level record a state appeal statute requires before the filing window closes. If your pharmacy is being reimbursed below acquisition cost under a PBM's MAC list, or a MAC appeal has been denied, contact us for a free, confidential consultation.
